Status:
WITHDRAWN
Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
Lead Sponsor:
Stanford University
Conditions:
Retinoblastoma
Eye Cancer
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE2
Brief Summary
Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma
Eligibility Criteria
Inclusion
- Patients diagnosed with advanced intraocular retinoblastoma (International Retinoblastoma Classification group D or E\*).
- Patients with tumor recurrence or vitreous seeding following completion of systemic chemotherapy or previous radiation therapy.
Exclusion
- Congenital brain anomaly identified on MRI.
- History of systemic coagulopathy.
- Evidence of extra ocular retinoblastoma on clinical examination or neuroimaging.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01151748
Start Date
September 1 2010
End Date
March 1 2012
Last Update
May 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305